Membrane lipid peroxidation (MLP) in Alzheimer's (AD) and Parkinson's (PD) brains and role of protease-activated receptor-1 (PAR-1).

被引：0
|
作者：
Ameenuddin, JS
Landis, M
SantaCruz, KS
Festoff, BW
机构：
[1] Vet Adm Med Ctr, Neurobiol Res Lab, Kansas City, MO 64128 USA
[2] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66170 USA
[3] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66170 USA
[4] Univ Kansas, Med Ctr, Dept Pharmacol, Kansas City, KS 66170 USA
来源：
JOURNAL OF NEUROCHEMISTRY | 2000年 / 74卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] Protease-activated receptor-1 (PAR-1) increases intracellular calcium and mediates chloride secretion in an epithelial cell line
    Buresi, MC
    Schleihauf, E
    Vergnolle, N
    Chapman, K
    Buret, A
    Wallace, JL
    Hollenberg, MD
    MacNaughton, WK
    FASEB JOURNAL, 2000, 14 (04): : A114 - A114
  • [22] Suppression of ischaemia-induced injuries in rat brain by protease-activated receptor-1 (PAR-1) activating peptide
    Zhen, Xia
    Ng, Ethel Sau Kuen
    Lam, Francis Fu Yuen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 786 : 36 - 46
  • [23] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis
    Lin, C.
    Aberson, H. L.
    Von der Thusen, J.
    Borensztajn, K.
    Spek, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [24] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [25] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Yamaguchi, Akio
    ANTICANCER RESEARCH, 2008, 28 (2A) : 847 - 854
  • [26] Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats
    Andrade-Gordon, P
    Derian, CK
    Maryanoff, BE
    Zhang, HC
    Addo, MF
    Cheung, WM
    Damiano, BP
    D'Andrea, MR
    Darrow, AL
    De Garavilla, L
    Eckardt, AJ
    Giardino, EC
    Haertlein, BJ
    McComsey, DF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 34 - 42
  • [27] The role of protease activated receptor-1 (PAR-1) in tumor invasion and metastasis, angiogenesis, and mammary gland morphogenesis
    Salah, Z
    Yin, YJ
    Maoz, M
    Cohen, I
    Uziely, B
    Grisaru-Granovsky, S
    Bar-Shavit, R
    PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON TUMOR MICROENVIRONMENT PROGRESSION, THERAPY & PREVENTION, 2002, : 133 - 139
  • [28] IN VIVO PROTEASE-ACTIVATED RECEPTOR-1 MEDIATED CORONARY VASOREACTIVITY CORRELATES WITH PAR-1 EXPRESSION DISTRIBUTION IN THE CORONARY VASCULAR WALL
    Kasasbeh, E. S.
    Phillips, S. A.
    Couhtino, L.
    Williams, P.
    Nunnally, A. H.
    Adcock, J.
    Wang, L.
    Hamm, H. E.
    Cleator, J. H.
    CARDIOLOGY, 2015, 131 : 285 - 285
  • [29] Expression of protease-activated receptor-1 (PAR-1): A differential marker for metastasis of squamous cell carcinoma of the head and neck (SCCHN)
    Zhang, X
    Hunt, JL
    Landsittel, DP
    Shin, DM
    Chen, ZG
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1309S - 1309S
  • [30] The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
    Nilsen, Dennis W. T.
    Roysland, Michelle
    Ueland, Thor
    Aukrust, Pal
    Michelsen, Annika E.
    Staines, Harry
    Barvik, Stale
    Kontny, Frederic
    Nordrehaug, Jan Erik
    Bonarjee, Vernon V. S.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 510 - 521
12345